Recent News

• 11.13.2025 - Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference
• 11.12.2025 - Paysign, Inc. Reports Third Quarter 2025 Financial Results
• 11.10.2025 - Paysign is Attending the Trade and Channel Strategies, Philadelphia, PA
• 10.22.2025 - Paysign is a Sponsor at the Patient Support Services Congress, East Brunswick, NJ
• 10.21.2025 - Paysign is a Sponsor and Speaker at the Copay, Reimbursement and Access Congress, East Brunswick, NJ
• 10.14.2025 - Paysign to Host Third Quarter 2025 Earnings Call
• 09.23.2025 - Paysign is a Sponsor at the 2025 PPTA Plasma Protein Forum, Alexandria, VA
• 09.22.2025 - Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions
• 09.15.2025 - Paysign, Inc. Announces Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
• 09.15.2025 - Paysign, Inc. Opens 30,000 Square Foot Patient Service Support Center to Meet Growing Demand in Patient Affordability Business

Recent Filings

• 11.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.12.2025 - 8-K Current report
• 09.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.16.2025 - EX-99.1 EX-99.1
• 09.16.2025 - 8-K Current report